International Journal of Pharma and Bio Sciences
    ISSN 0975-6299

Int J Pharm Bio Sci Volume 12 Issue 3, 2021 (July-September), Pages:56-62

Phenotypic Detection of Metallo- Beta-Lactamase (MBL) Producing Gram-Negative Bacteria and their Prevalence in a Tertiary Care Cancer Centre

Parthiban Rudrapathy, Athira KV, Sajani Samuel and Saravanan Murugesan

Gram-negative bacteria (GNB), particularly Enterobacteriaceae are a major cause of healthcare-associated infection. More over Infections caused by resistant organisms result in a tremendous morbidity and mortality worldwide. In the last few years carbapenem resistant gram-negative organisms have become a serious threat to cancer patients. The objective of this study is to detect the prevalence of MBL producers in various clinical samples by phenotypic methods. This is hospital based cross-sectional study. A total of 110 GNB isolates from various clinical samples were included in the study. Phenotypic detection of Metallo ß-lactamases (MBLs) was carried out by Modified Hodge test (MHT) and Disc Potentiation test (DPT). Out of 110 GNB isolates, E. coli was the predominant species (n = 45), followed by K. pneumoniae (n = 37) and P. aeruginosa (n = 16) K. pneumoniae (n = 11; 28%) showed maximum production of MBL by phenotypic methods. The study underlines the problem of MBL mediated resistance, which has created a therapeutic challenge for the clinicians and microbiologists. Simple disc diffusion methods can be routinely employed to detect these common resistance mechanisms which will reduce the mortality and also spread of such resistant strains.

Keywords: Metallo ß-lactamases, Gram-negative bacteria, Carbapenem resistance, Cancer patients.
Full HTML:
  1. Rolston KV. Infections in cancer patients with solid tumors: a review. Infect Dis Ther. 2017; 6(1):69-83. doi: 10.1007/s40121-017-0146-1.
  2. Royo-Cebrecos C, Gudiol C, Ardanuy C, Pomares H, Calvo M, Carratalà J. A fresh look at polymicrobial bloodstream infection in cancer patients. PLoS One. 2017; 12(10):e0185768. doi:org/10.1371/journal.pone.0185768. 
  3. Beyene D, Bitew A, Fantew S, Mihret A, Evans M. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019 Sep 25;14(9):e0222911. doi: 10.1371/journal.pone.0222911.
  4. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? ClinMicrobiol Rev. 2005; 18(2):306-25. doi: 10.1128/CMR.18.2.306-325.2005. 
  5. Logan LK, Weinstein RA. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017;S28-S36. doi: 10.1093/infdis/jiw282. 
  6. Codjoe FS, Donkor ES. Carbapenem Resistance: A Review. Med Sci (Basel). 2018; 6(1):1. doi:org/10.3390/medsci6010001. 
  7. Tekele SG, Teklu DS, Tullu KD, Birru SK, Legese MH. Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia. PLoS One. 202;15(11):e0241984. doi: 10.1371/journal.pone.0241984. 
  8. Pawar S, Mohite ST, Datkhile K, Patil MN, Durgawale PP, Patil SR. Closing the Gap Between Phenotypic and Genotypic Detection of Carbapenem Resistant Enterobacteriaceae by New Modified Carbapenem Inactivation Method. J of Clin. and Diag. Res. 2018;12(11).DC01 – DC04.DOI:10.7860/JCDR/2018/37940.12192.
  9. Clinical and Laboratory Standards Institute CLSI. Screening and Confirmatory Tests for Suspected Carbapenemases Production. 2010; 20 supplemental table 2A-S2. 
  10. Yong D, Lee Y, Jeong SH, Lee K, Chong Y. Evaluation of double-disk potentiation and disk potentiation tests using dipicolinic acid for detection of metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. J ClinMicrobiol. 2012;50(10):3227-32. doi: 10.1128/JCM.00818-12.
  11. Veeraraghavan B, Walia K. Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India. Indian J Med Res. 2019;149(2):87-96. doi: 10.4103/ijmr.
  12. Cheesbrough M. Bacterial pathogens. In: District Laboratory Practices in Tropical Countries. Vol.  2.  London:  Cambridge University Press; 2006.  
  13. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-seventh Informational Supplement. Wayne, PA: CLSI; 2017. 
  14. Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-β-lactamase,AmpC,and carbapen
  15. emase-producingEnterobacteriaceae. ClinMicrobiol Rev 2018; 31(2): e00079-17. doi: 10.1128/CMR.00079-17.
  16. Kazmierczak KM, Rabine S, Hackel M, McLaughlin RE, Biedenbach DJ, Bouchillon SK et al. Multiyear, multinational survey of the incidence and global distribution of metallo-β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016; 60(2):1067-78. doi: 10.1128/AAC.02379-15.
  17. Khosravi Y, Loke MF, Chua EG, Tay ST, Vadivelu J. Phenotypic detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa. Scientific World Journal. 2012; 2012:654939. doi:org/10.1100/2012/654939.
  18. Tamma PD, Simner PJ. Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates. J ClinMicrobiol. 2018; 56(11):e01140-18. doi:10.1128/JCM.01140-18.
  19. Alemayehu T, Asnake S, Tadesse B, Azerefegn E, Mitiku E, Agegnehu A, et al. Phenotypic Detection of Carbapenem-Resistant Gram-Negative Bacilli from a Clinical Specimen in Sidama, Ethiopia: A Cross-Sectional Study. Infect Drug Resist. 2021; 14(2):369-380. doi: 10.2147/IDR.S289763. 
  20. Veeraraghavan B, Jesudason MR, Prakasah JAJ, Anandan S, Sahni RD, Pragasam AK, et al. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report. Indian J Med Microbiol. 2018;36(1):32-36. doi: 10.4103/ijmm.IJMM_17_415. 
  21. Chauhan K, Pandey A, Asthana AK, Madan M. Evaluation of phenotypic tests for detection of Klebsiellapneumoniaecarbapenemase and metallo-beta-lactamase in clinical isolates of Escherichia coli and Klebsiella species. Indian J PatholMicrobiol. 2015; 58(1):31-5. doi: 10.4103/0377-4929.151168. 
  22. Hirakata Y, Yamaguchi T, Nakano M, Izumikawa K, Mine M, Aoki S, et al. Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis. 2003;37(1):26-32. doi: 10.1086/375594. 
  23. Agrawal R. Simple Method for Detection of Metallo–β–Lactamase among Gram Negative Isolates. Online J Health Allied Scs. 2015; 14(3):6.
  24. Anwar M, Ejaz H, Zafar A, Hamid H. Phenotypic Detection of Metallo-Beta-Lactamases in Carbapenem Resistant Acinetobacterbaumannii Isolated from Pediatric Patients in Pakistan. J Pathog. 2016; 2016:8603964. doi: 10.1155/2016/8603964. 
  25. Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy. Front Microbiol. 2019;10:1823. doi:10.3389/fmicb.2019.01823.
  26. Diwakar J, Verma RK, Singh DP, Singh A, Kumari S. Phenotypic detection of carbapenem resistance in gram negative bacilli from various clinical specimens of a tertiary care hospital in Western Uttar Pradesh. Int J Res Med Sci. 2017;5(8):3511-4. DOI:
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions